- Home
- OCEAW vs LTH Comparison
OCEAW vs LTH Comparison
Compare OCEAW & LTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEAW
- LTH
- Stock Information
- Founded
- OCEAW N/A
- LTH 1992
- Country
- OCEAW United States
- LTH United States
- Employees
- OCEAW 7
- LTH N/A
- Industry
- OCEAW Biotechnology: Pharmaceutical Preparations
- LTH Hotels/Resorts
- Sector
- OCEAW Health Care
- LTH Consumer Discretionary
- Exchange
- OCEAW Nasdaq
- LTH Nasdaq
- Market Cap
- OCEAW N/A
- LTH N/A
- IPO Year
- OCEAW 2021
- LTH 2021
- Fundamental
- Price
- OCEAW $0.03
- LTH $29.85
- Analyst Decision
- OCEAW
- LTH Buy
- Analyst Count
- OCEAW 0
- LTH 12
- Target Price
- OCEAW N/A
- LTH $33.21
- AVG Volume (30 Days)
- OCEAW N/A
- LTH 2.2M
- Earning Date
- OCEAW N/A
- LTH 05-08-2025
- Dividend Yield
- OCEAW N/A
- LTH N/A
- EPS Growth
- OCEAW N/A
- LTH 100.00
- EPS
- OCEAW N/A
- LTH 0.74
- Revenue
- OCEAW N/A
- LTH $2,620,995,000.00
- Revenue This Year
- OCEAW N/A
- LTH $14.12
- Revenue Next Year
- OCEAW N/A
- LTH $11.10
- P/E Ratio
- OCEAW N/A
- LTH $40.61
- Revenue Growth
- OCEAW N/A
- LTH 18.24
- 52 Week Low
- OCEAW N/A
- LTH $12.34
- 52 Week High
- OCEAW N/A
- LTH $33.64
- Technical
- Relative Strength Index (RSI)
- OCEAW N/A
- LTH 47.60
- Support Level
- OCEAW N/A
- LTH $27.97
- Resistance Level
- OCEAW N/A
- LTH $32.27
- Average True Range (ATR)
- OCEAW 0.00
- LTH 1.75
- MACD
- OCEAW 0.00
- LTH -0.02
- Stochastic Oscillator
- OCEAW 0.00
- LTH 59.26
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.